Please provide your email address to receive an email when new articles are posted on . 12-month transplant-free survival rates were similar between patients who received rifaximin and those on ...
Please provide your email address to receive an email when new articles are posted on . The FDA has granted premarket approval to Sequana Medical’s alfapump implantable device for the treatment of ...
In its October 2024 meeting, the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) gave the green light for Korjuny (catumaxomab, Lindis Biotech GmbH) to be used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback